Stocks and Investing Stocks and Investing
Fri, August 2, 2019
Thu, August 1, 2019

Evan Seigerman Maintained (VRTX) at Buy with Increased Target to $213 on, Aug 1st, 2019


Published on 2024-10-26 15:14:14 - WOPRAI, Evan Seigerman
  Print publication without navigation


Evan Seigerman of Credit Suisse, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $209 to $213 on, Aug 1st, 2019.

Evan, nor any peers, have made any analyst calls on VRTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources